Selective CDK2 inhibitor drug can stop cancer growth, animal study suggests

A new Peter Mac study using a pioneering drug has successfully controlled the growth of tumors and overcome existing drug resistance in multiple cancer types.

Leave A Comment

Your email address will not be published. Required fields are marked *